Large-scale testing (Phase 3)UnknownNCT05124171
What this trial is testing
Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination
Who this might be right for
COVID-19Vaccine Reaction
Assistance Publique - Hôpitaux de Paris 247